Table 3. Pathophysiology of HFpEF involved in aging, female, and different comorbidities.
Common comorbidities in HFpEF | Involved pathophysiology |
General | |
Aging | LV diastolic dysfunction |
LV systolic dysfunction | |
Chronotropic incompetence | |
Systemic vascular dysfunction | |
Peripheral tissue abnormality | |
Female | LV diastolic dysfunction |
Coronary microvascular dysfunction | |
Systemic vascular dysfunction | |
Pulmonary vascular dysfunction | |
Cardiovascular | |
Atrial fibrillation | LV diastolic dysfunction |
LA dysfunction | |
Hypertension | LV diastolic dysfunction |
LV systolic dysfunction | |
LA dysfunction | |
Coronary microvascular dysfunction | |
Systemic vascular dysfunction | |
Coronary artery disease | LV diastolic dysfunction |
LV systolic dysfunction | |
Coronary microvascular dysfunction | |
Respiratory | |
Chronic obstructive pulmonary disease | LV diastolic dysfunction |
RV dysfunction | |
Sleep apnea syndrome | Pulmonary vascular dysfunction |
Metabolic | |
Diabetes mellitus | LV diastolic dysfunction |
Coronary microvascular dysfunction | |
Chronotropic incompetence | |
Systemic vascular dysfunction | |
Peripheral tissue abnormality | |
Obesity | LV diastolic dysfunction |
LV systolic dysfunction | |
Coronary microvascular dysfunction | |
Systemic vascular dysfunction | |
Peripheral tissue abnormality | |
Nephrogenic | |
Chronic kidney disease | LV diastolic dysfunction |
Coronary microvascular dysfunction | |
Systemic vascular dysfunction |
HFpEF, heart failure with preserved ejection fraction; LA, left atrial; LV, left ventricular; RV, right ventricular.